Vendor audit template

Vendor audit
template

Twelve rows, each scored 0, 1 or 2 from evidence you can see yourself. Use it on any supplier, and on us.

Short answerSafety & evidence · 7 min read · Updated 17 Nov 2026

A vendor audit scores a peptide supplier on twelve things you can check yourself: a named lab, a report per lot, purity and identity methods, endotoxin testing, the lot on the label, a live result page, a reachable scientist, cold chain, packaging, the claims on its site and how it discloses paid promotion. Score each 0, 1 or 2.

Key takeaways

  • Twelve rows, scored 0, 1 or 2 from evidence you can see, for a maximum of 24.
  • Read the zeros first: a 0 on lab, report per lot, purity method or identity method outweighs any total.
  • Rows 11 and 12 test honesty: human-use claims and undisclosed paid posts are red flags, not features.
  • A score describes paperwork and conduct for one lot; it says nothing about safety or effect in people.
  • We invite readers to audit 6AM with the same template.

01How to use the template

Pick one supplier. Collect what it shows you. Score each row from the evidence in front of you, not from what you are told.

1
Gather the evidence

The lab report for one lot, a photo of the vial label, the product listing, the supplier's contact page and one paid post by an affiliate or creator.

2
Score every row 0, 1 or 2

Use the descriptions in the last column. If you cannot see the evidence, the score is 0.

3
Read the zeros before the total

A 0 on rows 1 to 4 means the paperwork cannot support the vial, whatever the total. Then add up the rest; the maximum is 24.

4
Audit again when the lot changes

A score describes one lot and one moment. Rows 2, 3, 4 and 5 can change with every new batch.

02The scorecard

CheckWhat good looks likeRed flagScore (0/1/2)
1. Lab namedThe report names an independent testing lab, with its address, and that lab will confirm it issued the report.No lab named, a logo with no name, or the seller's own name in the lab field.0 none · 1 named · 2 named and the lab confirms the report
2. Report per lotA separate report for every lot, matched by lot number.One report used for every lot, or the same report image on several products.0 no report · 1 one report per product · 2 one report per lot
3. Purity methodPurity by HPLC, with the percentage and the chromatogram trace.A round figure such as "99%+" with no method and no trace.0 no purity result · 1 figure with method · 2 method and trace
4. Identity methodIdentity by mass spectrometry, with the observed mass next to the expected mass.Purity only, or "identity confirmed" with no data behind it.0 none · 1 stated without data · 2 mass spectrometry with both masses
5. Endotoxin testedAn endotoxin result with its units (EU/mg) and method (LAL or recombinant factor C).Not mentioned at all, or "pass" with no number and no method.0 none · 1 pass/fail only · 2 value, units and method
6. Lot on labelThe lot number printed on the vial label itself, matching the report.No lot number on the vial, or a sticker covering the original label.0 none · 1 on the outer box only · 2 on the vial, matching
7. Live result pageA page or QR code for each lot where the report can be opened and checked against the lot number.Reports only as screenshots, sent in private messages "on request".0 none · 1 on request · 2 a page per lot you can open yourself
8. Scientist reachableA named person with a science background who answers questions about methods and reports.Only a sales chat, and method questions go unanswered.0 no reply · 1 general support replies · 2 a scientist answers
9. Cold chainStated conditions for transit and storage, and packaging that matches what is stated.No information at all about temperature in transit or in storage.0 nothing stated · 1 storage advice only · 2 transit and storage stated and matched
10. Discreet packagingA plain outer box, and inside a full label: compound, contents in mg, lot and the research-use line.Contents disguised or declared as something they are not.0 disguised · 1 plain but label incomplete · 2 plain outside, full label inside
11. Claims on the siteProducts described by what they are (sequence, identity, purity), with research-use terms, and education kept apart from listings.Amounts, schedules, how-to-use guides, before-and-after pictures or outcome stories next to products.0 human-use claims · 1 research framing with lapses · 2 what it is, never what it does to people
12. Disclosure practiceCreators and affiliates label paid posts clearly, up front, and the seller says publicly that it pays them.Affiliate codes posted with no label, or paid reviews that are not marked.0 none · 1 inconsistent · 2 every paid post labelled

For research materials only. This template audits paperwork, labelling and conduct. It says nothing about use in people.

03Why these twelve rows

Rows 1 to 7 test the paperwork. They exist because a purity number alone answers very little. In its briefing for the July 2026 Pharmacy Compounding Advisory Committee, the FDA reported that most certificates of analysis it found for BPC-157 showed a purity result only, with no impurity limits. The same briefing noted that the certificate a nominator supplied for BPC-157 acetate mentioned no endotoxin test. Read more in endotoxin and sterility testing.

Row 6 borrows a rule from medicines. US regulations say the lot number on a drug label should lead back to the complete manufacturing history (21 CFR 201.18). Research vials are outside that rule; the logic still holds.

Rows 8 to 10 test the people and the handling. A supplier that cannot answer a method question cannot defend its own report. Packaging should protect the contents and your privacy, never hide what the contents are.

Rows 11 and 12 test honesty. In warning letters dated 24 August 2026, the FDA told five research-use peptide websites that their research-use labels did not settle the matter, citing product-page wording and the sale of bacteriostatic water alongside vials as evidence that the products were meant for people. On disclosure, the US Federal Trade Commission requires a material connection between an endorser and a seller to be disclosed clearly and conspicuously when the audience would not reasonably expect it (16 CFR 255.5). In the UK, the influencer guide from the ASA, CAP and the CMA says it must be obvious that an ad is an ad, and recommends a clear label such as #ad up front.

04What a score can't tell you

  • A score cannot confirm what is in a vial. Only a test of that vial, or of a retained sample from the same lot, can.
  • A perfect score can rest on a forged report. Row 1 asks you to confirm the report with the lab for that reason.
  • A high score says nothing about whether a compound is safe or effective in people. Those are evidence questions; see how we grade evidence.
  • We have not set a pass mark. Two suppliers on the same total can fail in very different places, which is why the zeros come first.

05Audit us too

We would like you to run this audit on 6AM. 6AM publishes a lab report for every batch on our quality page. Score us from what you can see, the same way you would score anyone else.

We have not scored ourselves here. Marking our own work would prove nothing. [When the testing lab and report scope are confirmed, publish 6AM's evidence for each row so readers can check it.]

If you audit us and find a gap, tell us through the contact page. For single vials rather than suppliers, use the 10-point safety checklist.

Educational content. Not medical advice. This is a plain-English summary of public sources as of 17 November 2026, not legal advice.

RefSources

  1. US Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee meeting, 23–24 July 2026 (BPC-157-related bulk drug substances). Advisory committee briefing, 2026. www.fda.gov/media/193343/download
  2. US Food and Drug Administration, CDER. Warning letter to Peak Performance Peptides, 735127 (one of five letters dated 24 August 2026). Warning letter, 2026. www.fda.gov/inspections-compliance-enforcement-and-criminal-…
  3. US Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2). Guidance for industry, March 2026. www.fda.gov/regulatory-information/search-fda-guidance-docum…
  4. US Food and Drug Administration. 21 CFR 201.18: Drugs; significance of control numbers. Code of Federal Regulations. www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-20…
  5. US Federal Trade Commission. 16 CFR 255.5: Disclosure of material connections. Code of Federal Regulations. www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-25…
  6. Advertising Standards Authority, Committee of Advertising Practice and Competition and Markets Authority. Influencers' guide to making clear that ads are ads. UK guidance. www.asa.org.uk/resource/influencers-guide.html
  7. National Institute of Standards and Technology. ISO/IEC 17025 crosswalk: reporting the results (clause 7.8). NIST document, 2018. www.nist.gov/document/7-8-17025-crosswalk-reporting-results-…
  8. ISO. ISO/IEC 17025: General requirements for the competence of testing and calibration laboratories. International standard. www.iso.org/ISO-IEC-17025-testing-and-calibration-laboratori…

Plain-English summary of public sources, not legal or medical advice. Last checked 17 Nov 2026.

Questions

What score should a good supplier get?

We have not set a pass mark. Read the zeros first: a 0 on any of rows 1 to 4 means the paperwork cannot support the vial, whatever the total.

Is a third-party tested label enough?

No. Third-party tested only means someone else ran a test. Rows 1 to 5 ask which lab, which lot, which methods and which results.

Why does discreet packaging matter?

Plain outer packaging protects the contents and your privacy. It should never hide what the contents are; a full label belongs on the vial inside.

Why is advertising disclosure part of a quality audit?

A supplier that hides paid promotion is telling you how it treats evidence. Clear labels on paid posts are also required in the US and the UK.

Can I audit 6AM with this?

Yes, and we would like you to. Score us from what you can see, the same way you would score anyone else.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page